Search
Denali Therapeutics Inc
DNLIAdd to Watchlist
20.000USD
-0.530-2.58%
Close 10-02 16:00（ET）
3.17BMarket Cap
LossP/E TTM
Pre-market 08:45 (ET)20.140USD+0.140+0.70%
Pre-market 08:45 (ET)TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-2.58%
5 Days
-1.91%
1 Month
-10.23%
6 Months
-3.15%
Year to Date
+21.14%
1 Year
+29.70%
Key Figures
20.850Open
20.850High
166.97KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.10%Turnover Ratio
20.530Prev. Close
19.932Low
3.35MTurnover
LossP/E Static
3.80P/B
0.00%Div Yield TTM
-40.04%ROA
27.30052wk High
34.63Volume Ratio
-422.77MNet Profit
158.71MShares
-2.8803EPS TTM
1.02Beta
-49.59%ROE
13.75052wk Low
4.41%Amplitude
76.61%Gross Margin
3.17BMarket Cap
1.98Reward/Risk
3.53%Risk Rate
Denali Therapeutics Inc's Score
0.24vs previous score
Forecast8.80
Financial Health6.98
Technical3.37
Valuation Dimensions7.39
Institutional Confidence10.00
Risk Assessment6.54
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Denali Therapeutics Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.68/-0.66
Revenue / Forecast
3.60M/14.61M
Denali Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolDNLI
Number of employees422
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Baillie Gifford & Co. | 7.60% |
| BlackRock Institutional Trust Company, N.A. | 6.56% |
| T. Rowe Price Investment Management, Inc. | 4.57% |
| Biogen Inc | 4.51% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 52.46% |
| Investment Advisor/Hedge Fund | 21.59% |
| Hedge Fund | 14.03% |
| Sovereign Wealth Fund | 7.64% |
Related Instruments
-0.61%
-1.02%
+1.11%
+0.34%
-0.04%
-0.51%
-1.04%
-1.87%
-0.21%
-1.14%
-0.40%
+0.53%
+0.38%
-1.84%
-0.32%
+0.05%
+0.57%
-1.79%
0.00%
-0.78%
FAQs
What is the current price of Denali Therapeutics Inc (DNLI)?
The current price of Denali Therapeutics Inc (DNLI) is 20.00.
What is the symbol of Denali Therapeutics Inc?
The ticker symbol of Denali Therapeutics Inc is DNLI.
What is the 52-week high of Denali Therapeutics Inc?
The 52-week high of Denali Therapeutics Inc is 27.30.
What is the 52-week low of Denali Therapeutics Inc?
The 52-week low of Denali Therapeutics Inc is 13.75.
What is the market capitalization of Denali Therapeutics Inc?
The market capitalization of Denali Therapeutics Inc is 3.17B.
Is Denali Therapeutics Inc (DNLI) currently rated as Buy, Hold, or Sell?
According to analysts, Denali Therapeutics Inc (DNLI) has an overall rating of Buy, with a price target of 36.53.
What is the Earnings Per Share (EPS TTM) of Denali Therapeutics Inc (DNLI)?
The Earnings Per Share (EPS TTM) of Denali Therapeutics Inc (DNLI) is -2.88.